↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Träfflista för sökning "L773:0263 6352 OR L773:1473 5598 ;pers:(Schmieder Roland E.)"

Sökning: L773:0263 6352 OR L773:1473 5598 > Schmieder Roland E.

Resultat 1-9 av 9

Sortera/gruppera träfflistan

Sortering: Träffar per sida:

Numrering	Referens	Omslagsbild	Hitta
1.	Mancia, Giuseppe, et al. (författare) 2007 Guidelines for the management of arterial hypertension : The task gorce for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) 2007 Ingår i: European Heart Journal. - Philadelphia : W.B. Saunders. - 0195-668X .- 1522-9645. ; 25:6, s. 1105-87 Tidskriftsartikel (refereegranskat)
2.	Mancia, Giuseppe, et al. (författare) 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC) 2013 Ingår i: Journal of Hypertension. - : Lippincott, Williams and Wilkins. - 0263-6352 .- 1473-5598. ; 31:10, s. 1925-1938 Tidskriftsartikel (refereegranskat)abstract n/a
3.	Jordan, Jens, et al. (författare) Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertension. 2012 Ingår i: Journal of Hypertension. - 1473-5598. ; 30:6, s. 1047-1055 Tidskriftsartikel (refereegranskat)abstract Obese patients are prone to arterial hypertension, require more antihypertensive medications, and have an increased risk of treatment-resistant arterial hypertension. Obesity-induced neurohumoral activation appears to be involved. The association between obesity and hypertension shows large inter-individual variability, likely through genetic mechanisms. Obesity affects overall cardiovascular and metabolic risk; yet, the relationship between obesity and cardiovascular risk is complex and not sufficiently addressed in clinical guidelines. The epidemiological observation that obesity may be protective in patients with established cardiovascular disease is difficult to translate into clinical experience and practice. Weight loss is often recommended as a means to lower blood pressure. However, current hypertension guidelines do not provide evidence-based guidance on how to institute weight loss. In fact, weight loss influences on blood pressure may be overestimated. Nevertheless, weight loss through bariatric surgery appears to decrease cardiovascular risk in severely obese patients. Eventually, most obese hypertensive patients will require antihypertensive medications. Data from large-scale studies with hard clinical endpoints on antihypertensive medications specifically addressing obese patients are lacking and the morbidity from the growing population of severely obese patients is poorly recognized or addressed. Because of their broad spectrum of beneficial effects, renin-angiotensin system inhibitors are considered to be the most appropriate drugs for antihypertensive treatment of obese patients. Most obese hypertensive patients require two or more antihypertensive drugs. Finally, how to combine weight loss strategies and antihypertensive treatment to achieve an optimal clinical outcome is unresolved.
4.	Mancia, Giuseppe, et al. (författare) 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. 2013 Ingår i: Journal of Hypertension. - 1473-5598. ; 31:10, s. 1925-1938 Tidskriftsartikel (refereegranskat)
5.	Mancia, Giuseppe, et al. (författare) Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document 2009 Ingår i: Journal of Hypertension. - 1473-5598. ; 27:11, s. 2121-2158 Forskningsöversikt (refereegranskat)
6.	Olsen, Michael H., et al. (författare) Agreement within Europe about antihypertensive treatment and education - results from the European Society of Hypertension questionnaire 2010 Ingår i: Journal of Hypertension. - 1473-5598. ; 28:7, s. 1593-1594 Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)
7.	Zanchetti, Alberto, et al. (författare) Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial. 2014 Ingår i: Journal of Hypertension. - 1473-5598. ; 32:9, s. 1888-1897 Tidskriftsartikel (refereegranskat)abstract The SBP values to be achieved by antihypertensive therapy in order to maximize reduction of cardiovascular outcomes are unknown; neither is it clear whether in patients with a previous cardiovascular event, the optimal values are lower than in the low-to-moderate risk hypertensive patients, or a more cautious blood pressure (BP) reduction should be obtained. Because of the uncertainty whether 'the lower the better' or the 'J-curve' hypothesis is correct, the European Society of Hypertension and the Chinese Hypertension League have promoted a randomized trial comparing antihypertensive treatment strategies aiming at three different SBP targets in hypertensive patients with a recent stroke or transient ischaemic attack. As the optimal level of low-density lipoprotein cholesterol (LDL-C) level is also unknown in these patients, LDL-C-lowering has been included in the design.
8.	Zanchetti, Alberto, et al. (författare) Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: a review of available trial evidence. 2014 Ingår i: Journal of Hypertension. - 1473-5598. ; 32:9, s. 1741-1750 Forskningsöversikt (refereegranskat)abstract It is well established by a large number of randomized controlled trials that lowering blood pressure (BP) and low-density lipoprotein cholesterol (LDL-C) by drugs are powerful means to reduce stroke incidence, but the optimal BP and LDL-C levels to be achieved are largely uncertain. Concerning BP targets, two hypotheses are being confronted: first, the lower the BP, the better the treatment outcome, and second, the hypothesis that too low BP values are accompanied by a lower benefit and even higher risk. It is also unknown whether BP lowering and LDL-C lowering have additive beneficial effects for the primary and secondary prevention of stroke, and whether these treatments can prevent cognitive decline after stroke.
9.	Zanchetti, Alberto, et al. (författare) Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke. 2016 Ingår i: Journal of Hypertension. - 1473-5598. ; 34:3, s. 393-396 Tidskriftsartikel (refereegranskat)

Skapa referenser, mejla, bekava och länka

Länka till träfflistan

Resultat 1-9 av 9

Avgränsa träffmängd

Typ av publikation: tidskriftsartikel (7); forskningsöversikt (2)

Typ av innehåll: refereegranskat (8); övrigt vetenskapligt/konstnärligt (1)

Författare/redaktör: Schmieder, Rolan... (9)Ta bort avgränsningen; Laurent, Stephane (8); Viigimaa, Margus (8); Cifkova, Renata (8); Narkiewicz, Krzyszto ... (8); Mancia, Giuseppe (8); visa fler...; Dominiczak, Anna (8); Zanchetti, Alberto (8); Nilsson, Peter (7); Redon, Josep (7); Grassi, Guido (6); Manolis, Athanasios ... (6); Agabiti-Rosei, Enric ... (6); Kjeldsen, Sverre E. (5); Erdine, Serap (5); Farsang, Csaba (5); Ruilope, Luis Miguel (5); Coca, Antonio (4); Fagard, Robert (4); Burnier, Michel (4); Rodicio, Jose Luis (3); Silani, Vincenzo (3); Berge, Eivind (3); Zhang, Yuqing (3); Pinto, Fernando (3); Banach, Maciej (3); De Backer, Guy (3); Dicker, Dror (3); O'Brien, John (3); Zambon, Antonella (3); Corrao, Giovanni (3); Jelakovic, Bojan (3); Scotti, Lorenza (3); Liu, Lisheng (3); Parati, Gianfranco (3); Lovic, Dragan (3); Zhu, Dingliang (3); Stramba-Badiale, Mar ... (3); Struijker Boudier, H ... (3); Mallion, Jean-Michel (3); Waeber, Bernard (3); Sirenko, Yuriy (3); Dorobantu, Maria (3); Konradi, Alexandra (3); Bilo, Grzegorz (3); Postadzhiyan, Arman (3); Zhang, Xinhua (3); Zhang, Xuezhong (3); Guan, Ting Rui (3); Wu, Zhaosu (3); visa färre...

Lärosäte: Lunds universitet (8); Umeå universitet (1); Linköpings universitet (1); Karolinska Institutet (1)

Språk: Engelska (9)

Forskningsämne (UKÄ/SCB): Medicin och hälsovetenskap (8)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - Nationella bibliotekssystem
LIBRIS.kb.se

pil uppåt

Stäng

Kopiera och spara länken för att återkomma till aktuell vy